Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults

Lactobacillus johnsonii N6.2 mitigates the onset of type 1 diabetes (T1D) in biobreeding diabetes-prone rats, in part, through changes in kynurenine:tryptophan (K:T) ratios. The goal of this pilot study was to determine the safety, tolerance, and general immunological response of L. johnsonii N6.2 i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Marcial, Guillermo E., Ford, Amanda L., Haller, Michael J., Gezan, Salvador A., Harrison, Natalie A., Cai, Dan, Meyer, Julie L., Perry, Daniel J., Atkinson, Mark A., Wasserfall, Clive H., Garrett, Timothy, Gonzalez, Claudio F., Brusko, Todd M., Dahl, Wendy J., Lorca, Graciela L.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2017
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5466969/
https://ncbi.nlm.nih.gov/pubmed/28659913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00655
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados